Desq Long
Sign in

Company

Mineralys Therapeutics, Inc.

MLYS · CIK 0001933414

SEC FORM 4
$3,005,302.72

Mineralys Therapeutics, Inc. (MLYS)

Sale of 104,320 shares at $28.8085 per share.

Reporting Person Slingsby Brian Taylor · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001963901-26-000003 · filed 2026-09-24 · View filing →

SEC FORM 4
$98,479.12

Mineralys Therapeutics, Inc. (MLYS)

Acquisition (code M) of 7,438 shares at $13.24 per share.

Reporting Person Warren Eric · Officer Title Chief Commercial Officer · Transaction Code M

Traded Sep 21, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001916048-26-000014 · filed 2026-09-22 · View filing →

SEC FORM 4
$209,135.73

Mineralys Therapeutics, Inc. (MLYS)

Sale of 7,438 shares at $28.1172 per share.

Reporting Person Warren Eric · Officer Title Chief Commercial Officer · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001916048-26-000014 · filed 2026-09-22 · View filing →

SEC FORM 4
$36,060.00

Mineralys Therapeutics, Inc. (MLYS)

Acquisition (code M) of 3,000 shares at $12.02 per share.

Reporting Person Karydas Daphne · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001816952-26-000005 · filed 2026-09-17 · View filing →

SEC FORM 4
$85,740.00

Mineralys Therapeutics, Inc. (MLYS)

Sale of 3,000 shares at $28.58 per share.

Reporting Person Karydas Daphne · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001816952-26-000005 · filed 2026-09-17 · View filing →

SEC FORM 4
$98,465.88

Mineralys Therapeutics, Inc. (MLYS)

Acquisition (code M) of 7,437 shares at $13.24 per share.

Reporting Person Warren Eric · Officer Title Chief Commercial Officer · Transaction Code M

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001916048-26-000012 · filed 2026-08-25 · View filing →

SEC FORM 4
$193,188.72

Mineralys Therapeutics, Inc. (MLYS)

Sale of 7,437 shares at $25.9767 per share.

Reporting Person Warren Eric · Officer Title Chief Commercial Officer · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001916048-26-000012 · filed 2026-08-25 · View filing →

SEC FORM 4
$34,720.00

Mineralys Therapeutics, Inc. (MLYS)

Acquisition (code M) of 2,170 shares at $16 per share.

Reporting Person Rodman David Malcom · Officer Title Chief Medical Officer · Transaction Code M

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001933414-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$58,785.30

Mineralys Therapeutics, Inc. (MLYS)

Sale of 2,170 shares at $27.09 per share.

Reporting Person Rodman David Malcom · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001933414-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$0.00

Mineralys Therapeutics, Inc. (MLYS)

Acquisition (code A) of 102,400 shares at $0 per share.

Reporting Person Ferguson James J. III · Officer Title Chief Medical Officer · Transaction Code A

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001933414-26-000120 · filed 2026-08-12 · View filing →